MicroRNA-375 targets Hippo-signaling effector YAP in liver cancer and inhibits tumor properties

Biochemical and Biophysical Research Communications

Volumn 394, Issue 3, 2010, Pages 623-627

  Liu, Angela M ^a,b   Poon, Ronnie T P ^a   Luk, John M ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Carcinogenesis; Hepatocellular carcinoma; Hippo signaling; MicroRNA; YAP

Indexed keywords

LUCIFERASE; MICRORNA; ONCOPROTEIN; PROTEIN YAP; UNCLASSIFIED DRUG;

ARTICLE; ASIA; CANCER PATIENT; CELL INVASION; CELL PROLIFERATION; CHINA; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; LIVER CELL CARCINOMA; MALE; ONCOGENE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN TARGETING; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HUMANS; LIVER NEOPLASMS; LUCIFERASES; MALE; MICRORNAS; NEOPLASM INVASIVENESS; NUCLEAR PROTEINS; TRANSCRIPTION FACTORS;

EID: 77950626836     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.03.036     Document Type: Article

References (21)

1. Hao K., Luk J.M., Lee N.P.Y., Mao M., Zhang C., Ferguson M.D., Lamb J., Dai H., Ng I.O., Sham P.C., and Poon R.T.P. Predicting prognosis in hepatocellular carcinoma after curative surgery with common clinicopathologic parameters. BMC Cancer 9 (2009) 389
2. Zender L., Spector M.S., Xue W., Flemming P., Cordon-Cardo C., Silke J., Fan S.-T., Luk J.M., Wigler M., Hannon G.J., Mu D., Lucito R., Powers S., and Lowe S.W. Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell 125 (2006) 1253-1267
3. Dong J., Feldmann G., Huang J., Wu S., Zhang N., Comerford S.A., Gayyed M.F., Anders R.A., Maitra A., and Pan D. Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 130 (2007) 1120-1133
4. Zeng Q., and Hong W. The emerging role of the hippo pathway in cell contact inhibition, organ size control, and cancer development in mammals. Cancer Cell 13 (2008) 188-192
5. Lu L., Li Y., Kim S.M., Bossuyt W., Liu P., Qiu Q., Wang Y., Halder G., Finegold M.J., Lee J.-S., and Johnson R.L. Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver. Proc. Natl. Acad. Sci. USA 107 (2010) 1437-1442
6. Xu M., Yao T., Lee N., Ng I., Chan Y., Zender L., Lowe S., Poon R., and Luk J. Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma. Cancer 115 (2009) 4576-4585
7. Overholtzer M., Zhang J., Smolen G.A., Muir B., Li W., Sgroi D.C., Deng C.-X., Brugge J.S., and Haber D.A. Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon. Proc. Natl. Acad. Sci. USA 103 (2006) 12405-12410
8. Meng F., Henson R., Wehbe-Janek H., Ghoshal K., Jacob S.T., and Patel T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133 (2007) 647-658
9. Johnson S.M., Grosshans H., Shingara J., Byrom M., Jarvis R., Cheng A., Labourier E., Reinert K.L., Brown D., and Slack F.J. RAS is regulated by the let-7 microRNA family. Cell 120 (2005) 635-647
10. Lee Y.S., and Dutta A. The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev. 21 (2007) 1025-1030
11. Yi X., Luk J.M., Lee N.P., Peng J., Leng X., Guan X.-Y., Lau G.K., Beretta L., and Fan S.-T. Association of mortalin (HSPA9) with liver cancer metastasis and prediction for early tumor recurrence. Mol. Cell. Proteomics 7 (2008) 315-325
12. Wang X.Q., Luk J.M., Leung P.P., Wong B.W., Stanbridge E.J., and Fan S.T. Alternative mRNA splicing of liver intestine-cadherin in hepatocellular carcinoma. Clin. Cancer Res. 11 (2005) 483-489
13. Wong K.-F., Luk J.M., Cheng R.H., Klickstein L.B., and Fan S.-T. Characterization of two novel LPS-binding sites in leukocyte integrin betaA domain. FASEB J. 21 (2007) 3231-3239
14. Liu L., Lee N., Chan V., Xue W., Zender L., Zhang C., Mao M., Dai H., Wang X., Xu M., Lee T., Ng I., Chen Y., Kung H., Lowe S., Poon R., Wang J., and Luk J. Targeting cadherin-17 inactivates Wnt signaling and inhibits tumor growth in liver carcinoma. Hepatology 50 (2009) 1453-1463
15. Lee N.P., Chen L., Lin M.C., Tsang F.H., Yeung C., Poon R.T., Peng J., Leng X., Beretta L., Sun S., Day P.J., and Luk J.M. Proteomic expression signature distinguishes cancerous and nonmalignant tissues in hepatocellular carcinoma. J. Proteome Res. 8 (2009) 1293-1303
16. Zhao B., Ye X., Yu J., Li L., Li W., Li S., Yu J., Lin J.D., Wang C.-Y., Chinnaiyan A.M., Lai Z.-C., and Guan K.-L. TEAD mediates YAP-dependent gene induction and growth control. Genes Dev. 22 (2008) 1962-1971
17. Ma L., Teruya-Feldstein J., and Weinberg R.A. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449 (2007) 682-688
18. El Ouaamari A., Baroukh N., Martens G.A., Lebrun P., Pipeleers D., and van Obberghen E. miR-375 targets 3′-phosphoinositide-dependent protein kinase-1 and regulates glucose-induced biological responses in pancreatic beta-cells. Diabetes 57 (2008) 2708-2717
19. Lee E.J., Gusev Y., Jiang J., Nuovo G.J., Lerner M.R., Frankel W.L., Morgan D.L., Postier R.G., Brackett D.J., and Schmittgen T.D. Expression profiling identifies microRNA signature in pancreatic cancer. Int. J. Cancer 120 (2007) 1046-1054
20. Ladeiro Y., Couchy G., Balabaud C., Bioulac-Sage P., Pelletier L., Rebouissou S., and Zucman-Rossi J. MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology 47 (2008) 1955-1963
21. Poy M.N., Eliasson L., Krutzfeldt J., Kuwajima S., Ma X., Macdonald P.E., Pfeffer S., Tuschl T., Rajewsky N., Rorsman P., and Stoffel M. A pancreatic islet-specific microRNA regulates insulin secretion. Nature 432 (2004) 226-230